In November 2024, a growth hormone suppression test was conducted and confirmed the diagnosis of acromegaly (Table 1), and a lesion measuring 8.9 × 8.8 mm was identified in the adenohypophysis, with slight rightward deviation of the infundibulum, without extrasellar invasion or optic chiasm involvement (Fig. 2). Here, GH1 is linked to acromegaly.